USRE30053EExpiredUtility
PG-type, 1,9-lactones
Priority: Jun 23, 1975Filed: Jan 16, 1978Granted: Jul 24, 1979
Est. expiryJun 23, 1995(expired)· nominal 20-yr term from priority
C07D 313/00C07D 309/12C07D 321/00C07C 405/00
38
PatentIndex Score
5
Cited by
4
References
3
Claims
Abstract
The present invention provides novel 1,9 lactones of prostaglandin-type free acids and a process for their preparation. These lactones are useful for the same pharmacological purposes as the corresponding prostaglandin-type free acids.
Claims
exact text as granted — not AI-modifiedI claim: .[.
1. A prostaglandin-type, 1,9-lactone of the formula ##STR280## wherein W 2 is ##STR281## wherein L 1 is ##STR282## or a mixture of ##STR283## wherein R 3 and R 4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R 3 and R 4 is fluoro, only when the other is hydrogen or fluoro; wherein M 1 is ##STR284## wherein R 5 is hydrogen or methyl; wherein R 7 is --(CH 2 ) m --CH 3 , wherein m is one to 5, inclusive, cis--CH═CH--CH 2 --CH 3 , or ##STR285## wherein T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, the various T's being the same or different, s is zero, one, 2, or 3, and Z 3 is oxa or methylene, with the provisio that not more than two T's are other than alkyl, and the further proviso that Z 3 is oxa only when R 3 and 4 4 are hydrogen or methyl, being the same or different; wherein Y 1 is trans--CH═CH--, --CH 2 CH 2 --, cis--CH═CH--, or --C.tbd.C--; and wherein Z 1 is cis--CH═CH--CH.sub.2 --(CH.sub.2).sub.g --CH.sub.2 --, (1) cis--CH═CH--CH.sub.2 --(CH.sub.2).sub.g --CF.sub.2 --, (2) cis--CH.sub.2 --CH═CH--(CH.sub.2).sub.g --CH.sub.2 --, (3) --(ch.sub.2).sub.3 --(ch.sub.2).sub.g --CH.sub.2 --, (4) --(ch.sub.2).sub.3 --(ch.sub.2).sub.g --CF.sub.2 --, (5) --ch.sub.2 --o--ch.sub.2 --(ch.sub.2).sub.g --CH.sub.2 --, (6) ##STR286## wherein g is one to 3, inclusive..]..[.
2. A compound according to claim 1, wherein W 2 is ##STR287## .[.
3. 11-Deoxy-PGF 2 α, 1,9-lactone, a compound according to claim 2..]..[.4. A compound according to claim 1, wherein W 2 is ##STR288##
.[.5. A compound according to claim 4, wherein Y 1 is --C.tbd.C--..]..[.6. 13,14-Didehydro-PGD 2 , 1,9-lactone, a compound according to claim 5..]..[.7. A compound according to claim 4, wherein Y 1 is cis--CH═CH--..]..[.8. cis-13-PGD 2 , 1,9-lactone..]..[.9. A compound according to claim 4, wherein Y 1 is --CH 2 CH 2 --..]..[.10. 13,14-Dihydro-PGD 2 , 1,9-lactone, a compound according to claim 9..]..[.11. A compound according to claim 4, wherein Y 1 is trans--CH═CH--..]..[.12. PGD 2 , 1,9-lactone, a compound according to claim 11..]..[.13. A compound according to claim 1, wherein W 2 is ##STR289##
.[.14. A compound according to claim 13, wherein ˜ is α..]..[.15. A compound according to claim 14, wherein M 1 ##STR290##
.[.16. 15-epi-PGF 2 α, 1,9-lactone, a compound according to 15..]..[.17. A compound according to claim 14, wherein M 1 is ##STR291##
.[.18. A compound according to claim 17, wherein Z 1 is --CH 2 --O--CH 2 --(CH 2 ) g --CH 2 --..]..[.19. 5-oxa-PGF 1 α, 1,9-lactone, a compound according to claim 18..]. .[.20. A compound according to claim 17, wherein Z 1 is ##STR292##
.[.21. 3-oxa-3,7-inter-m-phenylene-4,5,6-trinor-PGF 1 α, 1,9-lactone, a compound according to claim 20..]..[.22. A compound according to claim 17, wherein Z 1 is ##STR293##
.[.23. 3,7-inter-m-phenylene-4,5,6-trinor-PGF 1 α, 1,9-lactone, a compound according to claim 22..]..[.24. A compound according to claim 17, wherein Z 1 is cis--CH 2 --CH═CH--(CH 2 ) g --CH 2 --..]. .[.25. cis-4,5-Didehydro-PGF 1 α, 1,9-lactone, a compound according to claim 24..]. .[.26. A compound according to claim 17, wherein Z 1 is cis--CH═CH--CH 2 --(CH 2 ) g --CF 2 --..]..[.27. 2,2,16,16-Tetrafluoro-PGF 2 α, 1,9-lactone, a compound according to claim 26..]..[.28. 2,2-Difluoro-16,16-dimethyl-PGF 2 α,1,9-lactone, a compound according to claim 26..]. .[.29. 2,2-Difluoro-15-methyl-PGF 2 α, 1,9-lactones, a compound according to claim 26..]..[.30. 2,2-Difluoro-PGF 2 α, 1,9-lactone, a compound according to claim 26..]..[.31. A compound according to claim 17, wherein Z 1 is --(CH 2 ) 3 --(CH 2 ) g --CF 2 --..]..[.32. 2,2,16,16-Tetrafluoro-PGF 1 α, 1,9-lactone, a compound according
to claim 31..]..[.33. 2,2-Difluoro-16,16-dimethyl-PGF 1 α, 1,9-lactone, a compound according to claim 31..]..[.34. 2,2-Difluoro-15-methyl-PGF 1 α, 1,9-lactone, a compound according to claim 31..]..[.35. 2,2-Difluoro-PGF 1 α, 1,9-lactone, a compound according to claim 31..]..[.36. A compound according to claim 17, wherein Z 1 is --(CH 2 ) 3 --(CH 2 ) g --CH 2 --..]..[.37. 16,16-Difluoro-PGF 1 α, 1,9-lactone, a compound according to claim 36..]..[.38. 16,16-Dimethyl-PGF 1 α, 1,9-lactone, a compound according to claim 36..]. .[.39. 15-Methyl-PGF 1 α, 1,9-lactone, a compound according to claim 36..]..[.40. PGF 1 α, 1,9-lactone, a compound according to claim 36..]..[.41. A compound according to claim 17, wherein Z 1 is cis--CH═CH--CH 2 --(CH 2 ) g --CH 2 --..]..[.42. A compound according to claim 41, wherein g is 3..]. .[.43. A compound
according to claim 41, wherein g is 1..]. .[.44. A compound according to claim 43, wherein Y 1 is --C.tbd.C--..]..[.45. 13,14-Didehydro-PGF 2 α, 1,9-lactone, a compound according to claim 44..]..[.46. A compound according to claim 43, wherein Y 1 is cis--CH═CH--..]..[.47. cis-13-PGF 2 α, 1,9-lactone, a compound according to claim 46..]..[.48. A compound according to claim 43, wherein Y 1 is --CH 2 CH 2 --..]..[.49. 13,14-dihydro PGF 2 α, 1,9-lactone, a compound according to claim 48..]..[.50. A compound according to claim 43, wherein Y 1 is trans--CH═CH--..]..[.51. A compound according to claim 50, wherein R 7 is cis--CH═CH--CH 2 --CH 3 --..]..[.52. PGF 3 α, 1,9-lactone, a compound according to claim 51..]..[.53. A compound according to claim 50, wherein 7 is ##STR294##
.[.54. A compound according to claim 53, wherein s is zero or one and T is chloro, fluoro, or trifluoromethyl..]..[.55. A compound according to claim 54, wherein Z 3 is methylene..]..[.56. A compound according to claim 55, wherein R 5 is methyl..]..[.57. 15-Methyl-17-Phenyl-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 56..]..[.58. A compound according to claim 55, wherein R 5 is hydrogen..]..[.59. A compound according to claim 58, wherein at least one of R 3 and R 4 are fluoro..]..[.60. 16,16-Difluoro-17-Phenyl-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 59..]..[.61. A compound according to claim 58, wherein at least one of R 3 and R 4 is methyl..]. .[.62. 16,16-Dimethyl-17-phenyl-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 61..]..[. 63. A compound according to claim
58, wherein R 3 and R 4 are both hydrogen..]..[.64. 17-Phenyl-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 63..]..[.65. A compound according to claim 54, wherein Z 3 is oxa..]..[.66. A compound according to claim 65, wherein R 5 is methyl..]..[.67. 15-Methyl-16-Phenoxy-17,18,19,20-tetranor-PGF 2 α, 1,9-lactone, a compound according to claim 66..]..[.68. A compound according to claim 65, wherein R 5 is hydrogen..]..[.69. A compound according to claim 68, wherein at least one of R 3 and R 4 is methyl..]..[.70. 16-Methyl-16-Phenoxy-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 69..]..[.71. A compound according to claim 68, wherein R 3 and R 4 are both hydrogen..]..[.72. 16-Phenoxy-17,18,19,20-tetranor-PGF 2 α, 1,9-lactone, a compound
according to claim 71..]..[.73. A compound according to claim 50, wherein R 7 , is --(CH 2 ) m --CH 3 --..]..[.74. A compound according to claim 73, wherein m is 30..]..[.75. A compound according to claim 74, wherein R 5 is methyl..]..[.76. A compound according to claim 75, wherein at least one of R 3 and R 4 is fluoro..]..[.77. 15-Methyl-16,16-difluoro-PGF 2 α, 1,9-lactone, a compound according to claim 76..]..[.78. A compound according to claim 75, wherein at least one of R 3 and R 4 is methyl..]..[.79. 15,16,16-Trimethyl-PGF 2 α, 1,9-lactone, a compound according to claim 78..]..[.80. A compound according to claim 75, wherein R 3 and R 4 are both hydrogen..]..[.81. 15-Methyl-PGF 2 α, 1,9-lactone, a compound according to claim 80..]. .[.82. A compound according to claim 74, wherein R 5 is hydrogen..]..[.83. A compound according to claim 82, wherein at least one of R 3 and R 4 is fluoro..]. .[.84. A compound according to claim 83, wherein R 3 and R 4 are both fluoro..]..[.85. 16,16-Difluoro-PGF 2 α, 1,9-lactone, a compound according to claim 84..]..[.86. A compound according to claim 82, wherein at least one of R 3 and R 4 is methyl..]..[.87. A compound according to claim 86, wherein R 3 and R 4 are both methyl..]..[.88. 16,16-Dimethyl-PGF 2 α, 1,9-lactone, a compound according to claim 87..]..[.89. A compound according to claim 82, wherein R 3 and R 4 are both hydrogen..]..[.90. PGF 2 α, 1,9-lactone, a compound according to
claim 89..]. .Iadd.91. A prostaglandin-type, 1,9-lactone of the formula ##STR295## wherein W 2 is ##STR296## wherein L 1 is ##STR297## or a mixture of ##STR298## wherein R 3 and R 4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R 3 and R 4 is fluoro, only when the other is hydrogen or fluoro; wherein M 1 is ##STR299## wherein R 5 is hydrogen or methyl; wherein R 7 is --(CH 2 ).sbsb.m--CH 3 , wherein m is one to 5, inclusive, cis--CH═CH--CH 2 --CH 3 , or ##STR300## wherein T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, the various T's being the same or different, s is zero, one, 2, or 3, with the proviso that not more than two T's are other than alkyl; wherein Y 1 is trans--CH═CH--, --CH 2 CH 2 --, cis--CH═CH--, or --C.tbd.C--; and wherein Z 1 is cis--CH═CH--CH.sub.2 --(CH.sub.2).sbsb.g--CH.sub.2 --,(1) cis--CH═CH--CH.sub.2 --(CH.sub.2).sbsb.g--CF.sub.2 --,(2) cis--CH.sub.2 --CH═CH--(CH.sub.2).sbsb.g--CH.sub.2 --,(3) --ch.sub.2).sub.3 --(ch.sub.2).sbsb.g--CH.sub.2 --, (4) --(ch.sub.2).sub.3 --(ch.sub.2).sbsb.g--CF.sub.2 --, (5) --ch.sub.2 --o--ch.sub.2 --(ch.sub.2).sbsb.g--CH.sub.2 --,(6) ##STR301##
wherein g is one to 3 inclusive. .Iaddend. .Iadd.92. A compound according to claim 91, wherein W 2 is ##STR302##
.Iaddend. .Iadd.93. 11-Deoxy-PGF 2 α, 1,9-lactone, a compound according to claim 92. .Iaddend..Iadd.94. A compound according to claim 91, wherein W 2 is ##STR303##
.Iaddend. .Iadd.95. A compound according to claim 94, wherein Y 1 is --C.tbd.C--. .Iaddend..Iadd.96. 13,14-Didehydro-PGD 2 , 1,9-lactone, a compound according to claim 95. .Iaddend..Iadd.97. A compound according to claim 94, wherein Y 1 is cis--CH═CH--. .Iaddend..Iadd.98. cis-13-PGD 2 , 1,9-lactone, a compound according to claim 97. .Iaddend..Iadd.99. A compound according to claim 94, wherein Y 1 is --CH 2 CH 2 --. .Iaddend..Iadd.100. 13,14-Dihydro-PGD 2 , 1,9-lactone, a compound according to claim 99. .Iaddend..Iadd.101. A compound according to claim 94, wherein Y 1 is trans--CH═CH--. .Iaddend..Iadd.102. PGD 2 1,9-lactone, a compound according to claim 101. .Iaddend..Iadd.103. A compound according to claim 91, wherein W 2 is ##STR304##
.Iaddend. .Iadd.104. A compound according to claim 103, wherein ˜ is α..Iaddend..Iadd.105. A compound according to claim 104, wherein M 1 is ##STR305##
.Iaddend. .Iadd.106. 15-epi-16-Methyl-PGF 2 α, 1,9-lactone, a compound according to claim 105. .Iaddend..Iadd.107. A compound according to claim 104, wherein M 1 is ##STR306##
.Iaddend. .Iadd.108. A compound according to claim 107, wherein Z 1 is --CH 2 --O--CH 2 --(CH 2 ).sbsb.g--CH 2 --. .Iaddend..Iadd.109. 5-Oxa-PGF 1 α, 1,9-lactone, a compound according to claim 108. .Iaddend..Iadd.110. A compound according to claim 107, wherein Z 1 is ##STR307##
.Iaddend. .Iadd.111. 3-Oxa-3,7-inter-m-phenylene-4,5,6-trinor-PGF 1 α, 1,9-lactone, a compound according to claim 110. .Iaddend..Iadd.112. A compound according to claim 107, wherein Z 1 is ##STR308##
.Iaddend. .Iadd.113. 3,7-inter-m-phenylene-4,5,6-trinor-PGF 1 α, 1,9-lactone, a compound according to claim 112. .Iaddend..Iadd.114. A compound according to claim 107, wherein Z 1 is cis--CH 2 --CH═CH--(CH 2 ).sbsb.g--CH 2 --. .Iaddend..Iadd.115. cis-4,5-Didehydro-PGF 1 α, 1,9-lactone, a compound according to claim 114. .Iaddend..Iadd.116. A compound according to claim 107, wherein Z 1 is cis--CH═CH--CH 2 --(CH 2 ).sbsb.g--CF 2 --. .Iaddend..Iadd.117. 2,2,16,16-Tetrafluoro-PGF 2 α, 1,9-lactone, a compound according to claim 116. .Iaddend.. .Iadd.118. 2,2-Difluoro-16,16-dimethyl-PGF 2 α, 1,9-lactone, a compound according to claim 116. .Iaddend..Iadd.119. 2,2-Difluoro-15-methyl-PGF 2 α, 1,9-lactone, a compound according to claim 116. .Iaddend..Iadd.120. 2,2-Difluoro-PGF 2 α, 1,9-lactone, a compound according to claim 116. .Iaddend..Iadd.121. A compound according to claim 107, wherein Z 1 is --(CH 2 ) 3 --(CH 2 ).sbsb.g--CF 2 --. .Iaddend..Iadd.122. 2,2,16,16-Tetrafluoro-PGF 1 α, 1,9-lactone, a compound according
to claim 121. .Iaddend..Iadd.123. 2,2-Difluoro-16,16-dimethyl-PGF 1 α, 1,9-lactone, a compound according to claim 121. .Iaddend..Iadd.124. 2,2-Difluoro-15-methyl-PGF 1 α, 1,9-lactone, a compound according to claim 121. .Iaddend..Iadd.125. 2,2-Difluoro-PGF 1 α, 1,9-lactone, a compound according to claim 121. .Iaddend..Iadd.126. A compound according to claim 107, wherein Z 1 is --(CH 2 ) 3 --(CH 2 ).sbsb.g--CH 2 --. .Iaddend..Iadd.127. 16,16-Difuoro-PGF 1 α, 1,9-lactone, a compound according to claim 126. .Iaddend..Iadd.128. 16,16-Dimethyl-PGF 1 α, 1,9-lactone, a compound according to claim 126. .Iaddend..Iadd.129. 15-Methyl-PGF 1 α, 1,9-lactone, a compound according to claim 126. .Iaddend..Iadd.130. PGF 1 α, 1,9-lactone, a compound according to claim 126. .Iaddend..Iadd.131. A compound according to claim 107, wherein Z 1 is cis--CH═CH--CH 2 --(CH 2 ).sbsb.g--CH 2 --. .Iaddend..Iadd.132. A compound according to claim 131, wherein g is 3. .Iaddend..Iadd.133. A compound according to claim 131, wherein g is one.
.Iaddend..Iadd.134. A compound according to claim 133 wherein Y 1 is --C.tbd.C--. .Iaddend..Iadd.135. 13,14-Didehydro-PGF 2 α, 1,9-lactone, a compound according to claim 134. .Iaddend..Iadd.136. A compound according to claim 133, wherein Y 1 is cis--CH═CH--. .Iaddend..Iadd.137. cis-13-PGF 2 α, 1,9-lactone, a compound according to claim 136. .Iaddend..Iadd.138. A compound according to claim 133, wherein Y 1 is --CH 2 CH 2 --. .Iaddend..Iadd.139. 13,14-Dihydro-PGF 2 α, 1,9-lactone, a compound according to claim 138. .Iaddend..Iadd.140. A compound according to claim 133, wherein Y 1 is trans--CH═CH--. .Iaddend..Iadd.141. A compound according to claim 140, wherein R 7 is cis--CH═CH--CH 2 --CH 3 --. .Iaddend..Iadd.142. PGF 3 α, 1,9-lactone, a compound according to claim 141. .Iaddend..Iadd.143. A compound according to claim 140, wherein R 7 is ##STR309##
.Iaddend. .Iadd.144. A compound according to claim 143, wherein s is zero
or one and T is chloro, fluoro, or trifluoromethyl. .Iaddend..Iadd.145. A compound according to claim 144, wherein R 5 is methyl. .Iaddend..Iadd.146. 15-Methyl-17-phenyl-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 145. .Iaddend..Iadd.147. A compound according to claim 144, wherein R 5 is hydrogen. .Iaddend..Iadd.148. A compound according to claim 147, wherein at least one of R 3 and R 4 is fluoro. .Iaddend..Iadd.149. 16,16-Difluoro-17-phenyl-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 148. .Iaddend..Iadd.150. A compound according to claim 147, wherein at least one of R 3 and R 4 is methyl. .Iaddend..Iadd.151. 16,16-Dimethyl-17-phenyl-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 150. .Iaddend..Iadd.152. A compound according to claim 147, wherein R 3 and R 4 are both hydrogen. .Iaddend..Iadd.153. 17-Phenyl-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 152. .Iaddend..Iadd.154. A compound according to claim 140, wherein R 7 is --(CH 2 ).sbsb.m--CH 3 --. .Iaddend..Iadd.155. A compound according to claim 154, wherein m is 3. .Iaddend..Iadd.156. A compound according to claim 155, wherein R 5 is
methyl. .Iaddend..Iadd.157. A compound according to claim 156, wherein at least one of R 3 and R 4 is fluoro. .Iaddend..Iadd.158. 15-Methyl-16,16-difuoro-PGF 2 α, 1,9-lactone, a compound according to claim 157. .Iaddend..Iadd.159. A compound according to claim 156, wherein at least one of R 3 and R 4 is methyl. .Iaddend..Iadd.160. 15,16,16-Trimethyl-PGF 2 α, 1,9-lactone, a compound according to claim 159. .Iaddend..Iadd.161. A compound according to claim 156, wherein R 3 and R 4 are both hydrogen. .Iaddend..Iadd.162. 15-Methyl-PGF 2 α, 1,9-lactone, a compound according to claim 161. .Iaddend..Iadd.163. A compound according to claim 155, wherein R 5 is hydrogen. .Iaddend..Iadd.164. A compound according to claim 163, wherein at least one of R 3 and R 4 is fluoro. .Iaddend..Iadd.165. A compound according to claim 164, wherein R 3 and R 4 are both fluoro. .Iaddend..Iadd.166. 16,16-Difluoro-PGF 2 α, 1,9-lactone, a compound according to claim 165.
.Iaddend..Iadd. . A compound according to claim 163, wherein at least one of R 3 and R 4 is methyl. .Iaddend..Iadd.168. A compound according to claim 167, wherein R 3 and R 4 are both methyl. .Iaddend..Iadd.169. 16,16-Dimethyl-PGF 2 α, 1,9-lactone, a compound according to claim 168. .Iaddend..Iadd.170. A compound according to claim 163, wherein R 3 and R 4 are both hydrogen. .Iaddend..Iadd.171. PGF 2 α, 1,9-lactone, a compound according
to claim 170. .Iaddend..Iadd.172. A prostaglandin-type, 1,9-lactone of the formula ##STR310## wherein W 2 is ##STR311## wherein L 1 is ##STR312## or a mixture of ##STR313## wherein R 3 and R 4 are hydrogen or methyl being the same or different; wherein M 1 is ##STR314## wherein R 5 is hydrogen or methyl wherein T is chloro, fluoro, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, the various T's being the same or different, s is zero, one, 2, or 3, with the proviso that not more than two T's are other than alkyl; wherein Y 1 is trans--CH═CH--, --CH 2 CH 2 --, cis--CH═CH--, or --C.tbd.C--; and wherein Z 1 is cis--CH═CH--CH.sub.2 --(CH.sub.2).sbsb.g--CH.sub.2 --,(1) cis--CH═CH--CH.sub.2 --(CH.sub.2).sbsb.g--CF.sub.2 --,(2) cis--CH.sub.2 --CH═CH--(CH.sub.2).sbsb.g--CH.sub.2 --,(3) --(ch.sub.2).sub.3 --(ch.sub.2).sbsb.g--CH.sub.2 --, (4) --(ch.sub.2).sub.3 --(ch.sub.2).sbsb.g--CF.sub.2 --, (5) --ch.sub.2 --o--ch.sub.2 --(ch.sub.2).sbsb.g--CH.sub.2 --,(6) ##STR315##
wherein g is one to 3, inclusive. .Iaddend..Iadd.173. A compound according to claim 172, wherein W 2 is ##STR316##
.Iaddend. .Iadd.174. A compound according to claim 172, wherein W 2 is ##STR317##
.Iaddend. .Iadd.175. A compound according to claim 174, wherein Y 1 is --C.tbd.C--. .Iaddend..Iadd.176. A compound according to claim 174, wherein Y 1 is cis--CH═CH--. .Iaddend..Iadd.177. A compound according to claim 174, wherein Y 1 is --CH 2 CH 2 --..Iaddend..Iadd.178. A compound according to claim 174, wherein Y 1 is trans--CH═CH--. .Iaddend..Iadd.179. A compound according to claim 172, wherein W 2 is ##STR318##
.Iaddend. .Iadd.180. A compound according to claim 179, wherein ˜ is α..Iaddend..Iadd.181. A compound according to claim 180, wherein M 1 is ##STR319##
.Iaddend. .Iadd.182. A compound according to claim 180, wherein M 1 is ##STR320##
.Iaddend. .Iadd.183. A compound according to claim 182, wherein Z 1 is --CH 2 --O--CH 2 --(CH 2 ).sbsb.g--CH 2 --. .Iaddend..Iadd.184. A compound according to claim 182, wherein Z 1 is ##STR321##
.Iaddend. .Iadd.185. A compound according to claim 182, wherein Z 1 is ##STR322##
.Iaddend. .Iadd.186. A compound according to claim 182, wherein Z 1 is cis--CH 2 --CH═CH--(CH 2 ).sbsb.g--CH 2 --. .Iaddend..Iadd.187. A compound according to claim 182, wherein Z 1 is cis--CH═CH--CH 2 --(CH 2 ).sbsb.g--CF 2 --. .Iaddend..Iadd.188. A compound according to claim 182, wherein Z 1 is --(CH 2 ) 3 --(CH 2 ).sbsb.g--CF 2 --. .Iaddend..Iadd.189. A compound according to claim 182, wherein Z 1 is --(CH 2 ) 3 --(CH 2 ).sbsb.g--CH 2 --. .Iaddend..Iadd.190. A compound according to claim 182, wherein Z 1 is cis--CH═CH--CH 2 --(CH 2 ).sbsb.g--CH 2 --. .Iaddend..Iadd.191. A compound according to claim 182, wherein g is 3. .Iaddend..Iadd.192. A compound according to claim 182, wherein g is one. .Iaddend..Iadd.193. A compound according to claim 192, wherein Y 1 is --C.tbd.C--. .Iaddend..Iadd.194. A compound according to claim 192, wherein Y 1 is cis--CH═CH--..Iaddend..Iadd.195. A compound according to claim 192, wherein Y 1 is trans--CH═CH--. .Iaddend..Iadd.196. A compound according to claim 192, wherein Y 1 is --CH 2 CH 2 --. .Iaddend..Iadd.197. A compound according to claim 196, wherein s is zero
or one and T is chloro, fluoro. .Iaddend..Iadd.198. A compound according to claim 197, wherein R 5 is methyl. .Iaddend..Iadd.199. 15-Methyl-16-phenoxy-17,18,19,20-tetranor-PGF 2 α, 1,9-lactone, a compound according to claim 198. .Iaddend..Iadd.200. A compound according to claim 197, wherein R 5 is hydrogen. .Iaddend..Iadd.201. A compound according to claim 200, wherein at least one of R 3 and R 4 is methyl. .Iaddend..Iadd.202. 16-Methyl-16-pheoxy-18,19,20-trinor-PGF 2 α, 1,9-lactone, a compound according to claim 201. .Iaddend..Iadd.203. A compound according to claim 200, wherein R 3 and R 4 are both hydrogen. .Iaddend..Iadd.204. 16-Phenoxy-17,18,19,20-tetranor-PGF 2 α, 1,9-lactone, a compound according to claim 203. .Iaddend.Join the waitlist — get patent alerts
Track USRE30053E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.